Natural Progress of High-Risk CLTI: The CLariTI Study 12-month Results
Watch as Dr. Anahita Dua discusses her ISET 2024 presentation on the 12-month results of the CLariTI Study.
Watch as Dr. Anahita Dua discusses her ISET 2024 presentation on the 12-month results of the CLariTI Study.
An 84-year-old woman was referred for transcatheter aortic valve replacement (TAVR) following severe symptomatic aortic stenosis (valve area 0.9 cm2, peak and mean transaortic pressure…
BackgroundThe heart can metabolize the microbiota‐derived short‐chain fatty acid butyrate. Butyrate may have beneficial effects in heart failure, but the underlying mechanisms are unknown. We…
The developing world has an epidemic of heart disease, and alternative options may help with delivery of care and cost. The LANDMARK trial looks at…
BACKGROUND: Tetraspanin CD151 is highly expressed in endothelia and reinforces cell adhesion, but its role in vascular inflammation remains largely unknown. METHODS: In vitro molecular…
In this video, Thomas Cuisset, PCR Course Director, and Davide Capodanno, EuroIntervention Editor-in-Chief, discuss key moments in coronary intervention at #…
A-A is a coalition of charities, patient groups, patients, carers, medical groups and allied professionals. A-A provides support, information, education, and awareness to all those…
BackgroundHypertension and hypercholesterolemia are important risk factors for cardiovascular disease, and treatment with fixed‐dose combination (FDC) regimens is recommended by current guidelines….
If you are expecting or recently had a baby, you know that it can be an exciting and joyful time. From doctor’s visits, where you…
Dr Jason Zagrodzky discusses his session ahead of Heart Rhythm 2024, which takes place May 16-19, 2024.
BACKGROUND: Hypertension is a highly prevalent cardiovascular disease risk factor that may be related to inflammation. Whether adverse levels of specific inflammatory cytokines relate to…